CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

RGA Investment Advisors, an investment management company, has released its second-quarter 2025 investor letter. A copy of ...

We recently compiled a list of the 10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood.

On the other hand, the stock currently carries a Zacks Rank of #2. So, this combination makes it difficult to conclusively predict that CRISPR Therapeutics AG will beat the consensus EPS estimate.